Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 59

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease

Tantucci, C., Donati, P., Nicosia, F., Bertella, E., Redolfi, S., De Vecchi, M., Corda, L., Grassi, V., Zulli, R.·2008·Respiratory Medicine

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.rmed.2007.11.004

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 23

  1. Pawels, 2001, Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD)—workshop summary, Am J Respir Crit Care Med, 163, 1256, 10.1164/ajrccm.163.5.2101039 · DOI
  2. Anthonisen, 1986, Prognosis in chronic obstructive pulmonary disease, Am Rev Respir Dis, 133, 14, 10.1164/arrd.1986.133.1.14 · DOI
  3. Tantucci, 1998, Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients, Eur Rspir J, 12, 799, 10.1183/09031936.98.12040799 · DOI
  4. O’Donnell, 1994, Breathlessness in patients with chronic airflow limitation. Mechanisms and management, Chest, 106, 904, 10.1378/chest.106.3.904 · DOI
  5. Tantucci, 2006, The Sara Study Group. Reference values and repeatability of inspiratory capacity for men and women aged 65–85, Resp Med, 100, 871, 10.1016/j.rmed.2005.08.017 · DOI
  6. 1991, Lung function testing; selection of reference values and interpretative startegies: American Thoracic Society Statement, Am Rev Respir Dis, 144, 1202, 10.1164/ajrccm/144.5.1202 · DOI
  7. Koulouris, 1995, A simple method to detect expiratory flow limitation during spontaneous breathing, Eur Respir J, 8, 306, 10.1183/09031936.95.08020306 · DOI
  8. Calverley, 2005, Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology, Eur Respir J, 25, 186, 10.1183/09031936.04.00113204 · DOI · Paper page
  9. O’Donnell, 2002, Exercise hypercapnia in advanced chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 166, 663, 10.1164/rccm.2201003 · DOI · Paper page
  10. Eltayara, 1996, Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 154, 1726, 10.1164/ajrccm.154.6.8970362 · DOI
  11. Eltayara, 2001, Orthopnea and tidal expiratory flow limitation in patients with stable COPD, Chest, 119, 99, 10.1378/chest.119.1.99 · DOI
  12. Martinez, 1997, Lung volume reduction improve dyspnoea, dynamic hyperinflation, and respiratory muscle function, Am J Respir Crit Care Med, 155, 1984, 10.1164/ajrccm.155.6.9196106 · DOI · Paper page
  13. Mahler, 1999, Efficacy of salmeterol xinafoate in the treatment of COPD, Chest, 115, 957, 10.1378/chest.115.4.957 · DOI
  14. Calverley, 2003, TRISTAN study. Combining salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial, Lancet, 361, 449, 10.1016/S0140-6736(03)12459-2 · DOI
  15. Vincken, 2002, Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium, Eur Respir J, 19, 209, 10.1183/09031936.02.00238702 · DOI
  16. Brusasco, 2003, Heath outcomes following teatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD, Thorax, 58, 399, 10.1136/thorax.58.5.399 · DOI
  17. Gerardi, 1996, Variables related to increased mortality following out-patient pulmonary rehabilitation, Eur Respir J, 431, 10.1183/09031936.96.09030431 · DOI
  18. Schols, 1998, Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 157, 1791, 10.1164/ajrccm.157.6.9705017 · DOI · Paper page
  19. Nishimura, 2002, Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD, Chest, 121, 1434, 10.1378/chest.121.5.1434 · DOI
  20. Pinto-Plata, 2004, The 6-minute walk distance: change over time and value as a predictor of survival in severe COPD, Eur RespirJ, 23, 28, 10.1183/09031936.03.00034603 · DOI
  21. Gray-Donald, 1996, Nutritional status and mortality in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 153, 961, 10.1164/ajrccm.153.3.8630580 · DOI
  22. Landbo, 1999, Prognostic value of nutritional status in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 160, 1856, 10.1164/ajrccm.160.6.9902115 · DOI
  23. Vestbo, 2006, Body mass, fat-free body mass and prognosis in patients with chronic obstructive pulmonary disease from a random population sample, Am J Respir Crit Care Med, 173, 79

Cited by

See all 59

Metadata

Authors
Tantucci, C., Donati, P., Nicosia, F., Bertella, E., Redolfi, S., De Vecchi, M., Corda, L., Grassi, V., & Zulli, R.
Venue
Respiratory Medicine
Publisher
Elsevier BV
Published
2008-04
Volume
102
Issue
4
Pages
613-619
ISSN
0954-6111
Cited by
59
References
6
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease. https://app.cochat.ai/papers/10.1016/j.rmed.2007.11.004
The paper
Tantucci, C., Donati, P., Nicosia, F., Bertella, E., Redolfi, S., De Vecchi, M., Corda, L., Grassi, V., & Zulli, R. (2008). Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease. Respiratory Medicine. https://doi.org/10.1016/j.rmed.2007.11.004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.